Desq Long
Sign in
SEC FORM 4
$9,346.50

Kiniksa Pharmaceuticals International, plc (KNSA)

Acquisition (code A) of 279 shares at $33.50 per share.

Reporting Person Megna Michael R · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code A

Traded Jul 15, 2026 · Disclosed Sep 3, 2026FILED +50 DAYS

Source: SEC Form 4 · 0001464583-26-000008 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Kiniksa Pharmaceuticals International, plc (KNSA)." Disclosed 2026-09-03. https://desqlong.com/cards/0001464583-26-000008-1 (retrieved 2026-09-26).